In the early 1950s, psychedelic drugs were considered promising treatments for a broad range of psychological and psychiatric conditions. For political reasons, their legal use for healing purposes was halted in the 1960s.

• MDMA was first made in 1912 and was used to improve psychotherapy in the 1970's. Both the non-medical and therapeutic use of MDMA were made illegal in 1985.

• Currently, one in six North Americans will suffer from PTSD in their lifetime.

• PTSD is highly correlated with depression, addiction, and suicide.

• According to a study published in the CNS Neuroscience & Therapeutics Post-traumatic stress disorder (PTSD) has become a global health issue, with prevalence rates ranging from 1.3% to 37.4%.

• 58 veterans committed suicide after their service in the Afghan War; many of them had PTSD.

• A study published in JAMA Psychiatry determined that roughly 271,000 Vietnam vets still have full war-zone-related PTSD that meets some diagnostic criteria 40 years after the war.

While there are various treatments available to those suffering from PTSD and related illnesses, the recovery rates and effectiveness of current treatments are low.

With your help, we can change these alarming statistics and help legalize psychedelic medicine.

MAPS Canada is in the process of conducting research investigating the effectiveness of MDMA-assisted psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD) with full approval and involvement from Health Canada and the U.S. Food and Drug Administration (FDA).

MDMA-assisted psychotherapy combines talk therapy with the use of MDMA, (3,4-methylenedioxymethamphetamine) a synthetic compound that enhances the effectiveness of the psychotherapy by helping patients feel more comfortable discussing difficult memories and emotions.

In a recently published study, 83% of subjects receiving MDMA-assisted psychotherapy no longer qualified for PTSD, and everyone who received a placebo and then went on to receive MDMA-assisted psychotherapy experienced significant and lasting improvements.

The long-term follow-up of subjects receiving MDMA-assisted psychotherapy revealed that on average overall benefits were maintained for 3½ years or more. Our Swiss study published in 2013 also found clinically significant improvements in PTSD symptoms after MDMA-assisted psychotherapy.

Independent medical research studies would not be possible without a community of supporters like yourself.

By making a contribution and sharing this campaign, you will help to make MDMA-assisted psychotherapy a legal, approved treatment by 2021. 

Every gift—no matter the size—makes a difference!

How your gift helps

Improving the way we heal our society through independent medical research studies is costly and would not be possible without a community of supporters like yourself.

Your contribution will go directly to helping legalize this therapy by paying for the cost of administering MDMA-assisted psychotherapy in our ongoing clinical trial for members of the community such as veterans and first responders who are suffering from chronic, treatment-resistant PTSD.

Every gift—no matter the size—makes a difference!

So every gift—no matter the size—makes a difference!

Path To Legalization

Matching Contributions

We have been fortunate enough to have two amazing sponsors offer dollar for dollar matching contributions to our campaign. 

Currently, Isomer Design has committed a pool of $10,000 in matching funds to this campaign. Your contribution will unlock their matching contribution dollar for dollar. For a limited time, this will create double the impact compared with regular donations. 

Nathan Babcock previously contributed $2500 in matching funds to our campaign which was unlocked the night of our launch party. 

If you would like to sponsor this campaign and match our donor's contributions please contact us at legalizepsychedelicmedicine AT gmail DOT com. We will feature you at the top of our campaign page and in our ongoing correspondance.